Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-09-16

AUTHORS

Tomoko Maeda, Yuko Miyazono, Kousei Ito, Kazuma Hamada, Shuichi Sekine, Toshiharu Horie

ABSTRACT

PurposeWe previously demonstrated the increase of reactive oxygen species (ROS) production and myeloperoxidase (MPO) activity in the small intestine of methotrexate (MTX)-treated rats. In the present study, we investigated the role of ROS modulating intestinal mucosal permeability in this damage.MethodMTX (20 mg/kg body weight) was administered to rats intravenously. N-Acetylcysteine (NAC; 80 mg/kg body wt), an antioxidant and a precursor of glutathione (GSH) was administered to rats intraperitoneally to investigate the contribution of ROS to the intestinal permeability enhancement. Intestinal permeability was evaluated by determining that of a poorly absorbable marker, fluorescein isothiocyanate-labeled dextran (FD-4; average molecular mass, 4.4 kDa) using the in vitro everted intestine technique. The occurrence of oxidative stress in the small intestine was assayed by measuring chemiluminescence and thiobarbituric acid reactive substances (TBARS) productions in mucosal homogenates of the small intestine.ResultsThe mucosal permeability of FD-4 significantly (p < 0.01) increased in MTX-treated rats compared with control rats, as demonstrated by a twofold increase of FD-4 permeation clearance. This suggests an increase in paracellular permeability. Interestingly, the ROS production was observed preceding the increase of paracellular permeability. Treatment with NAC prevented the MTX-induced ROS production and the increase of paracellular permeability.ConclusionsNAC protected the small intestine of rats from MTX-induced change in paracellular permeability, suggesting that ROS played an important role in the enhanced paracellular permeability. More... »

PAGES

1117-1123

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-009-1119-1

DOI

http://dx.doi.org/10.1007/s00280-009-1119-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050833962

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19756603


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acetylcysteine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimetabolites, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Weight", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dextrans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorescein-5-isothiocyanate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Free Radical Scavengers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glutathione", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intraperitoneal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intestinal Absorption", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intestinal Mucosa", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intestine, Small", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methotrexate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxidative Stress", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Permeability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Wistar", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reactive Oxygen Species", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thiobarbituric Acid Reactive Substances", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8675, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8675, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maeda", 
        "givenName": "Tomoko", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8675, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8675, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyazono", 
        "givenName": "Yuko", 
        "id": "sg:person.0752102243.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752102243.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Faculty of Medicine, The University of Tokyo Hospital, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.412708.8", 
          "name": [
            "Department of Pharmacy, Faculty of Medicine, The University of Tokyo Hospital, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ito", 
        "givenName": "Kousei", 
        "id": "sg:person.013142761762.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013142761762.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8675, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8675, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hamada", 
        "givenName": "Kazuma", 
        "id": "sg:person.01346736417.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346736417.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8675, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8675, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sekine", 
        "givenName": "Shuichi", 
        "id": "sg:person.014523410741.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014523410741.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8675, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8675, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Horie", 
        "givenName": "Toshiharu", 
        "id": "sg:person.015025434461.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015025434461.42"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00280-002-0460-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008558863", 
          "https://doi.org/10.1007/s00280-002-0460-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-008-0809-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032804435", 
          "https://doi.org/10.1007/s00280-008-0809-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002800050714", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015512224", 
          "https://doi.org/10.1007/s002800050714"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-09-16", 
    "datePublishedReg": "2009-09-16", 
    "description": "PurposeWe previously demonstrated the increase of reactive oxygen species (ROS) production and myeloperoxidase (MPO) activity in the small intestine of methotrexate (MTX)-treated rats. In the present study, we investigated the role of ROS modulating intestinal mucosal permeability in this damage.MethodMTX (20\u00a0mg/kg body weight) was administered to rats intravenously. N-Acetylcysteine (NAC; 80\u00a0mg/kg body wt), an antioxidant and a precursor of glutathione (GSH) was administered to rats intraperitoneally to investigate the contribution of ROS to the intestinal permeability enhancement. Intestinal permeability was evaluated by determining that of a poorly absorbable marker, fluorescein isothiocyanate-labeled dextran (FD-4; average molecular mass, 4.4\u00a0kDa) using the in vitro everted intestine technique. The occurrence of oxidative stress in the small intestine was assayed by measuring chemiluminescence and thiobarbituric acid reactive substances (TBARS) productions in mucosal homogenates of the small intestine.ResultsThe mucosal permeability of FD-4 significantly (p\u00a0<\u00a00.01) increased in MTX-treated rats compared with control rats, as demonstrated by a twofold increase of FD-4 permeation clearance. This suggests an increase in paracellular permeability. Interestingly, the ROS production was observed preceding the increase of paracellular permeability. Treatment with NAC prevented the MTX-induced ROS production and the increase of paracellular permeability.ConclusionsNAC protected the small intestine of rats from MTX-induced change in paracellular permeability, suggesting that ROS played an important role in the enhanced paracellular permeability.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00280-009-1119-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "65"
      }
    ], 
    "keywords": [
      "small intestine", 
      "mucosal permeability", 
      "paracellular permeability", 
      "methotrexate-treated rats", 
      "intestinal mucosal permeability", 
      "oxidative stress", 
      "precursor of glutathione", 
      "ROS production", 
      "thiobarbituric acid reactive substances (TBARS) production", 
      "reactive oxygen species (ROS) production", 
      "myeloperoxidase activity", 
      "control rats", 
      "intestinal permeability", 
      "oxygen species (ROS) production", 
      "absorbable marker", 
      "mucosal homogenates", 
      "intestine technique", 
      "rats", 
      "contribution of ROS", 
      "enhanced paracellular permeability", 
      "MTX", 
      "intestine", 
      "permeation clearance", 
      "role of ROS", 
      "species production", 
      "twofold increase", 
      "present study", 
      "fluorescein isothiocyanate", 
      "ROS", 
      "methotrexate", 
      "increase", 
      "important role", 
      "clearance", 
      "acetylcysteine", 
      "NAC", 
      "Intestinal permeability enhancement", 
      "treatment", 
      "homogenates", 
      "role", 
      "markers", 
      "FD-4", 
      "PurposeWe", 
      "glutathione", 
      "substance production", 
      "antioxidants", 
      "permeability", 
      "damage", 
      "production", 
      "stress", 
      "activity", 
      "study", 
      "dextran", 
      "isothiocyanate", 
      "chemiluminescence", 
      "occurrence", 
      "changes", 
      "permeability enhancement", 
      "enhancement", 
      "precursors", 
      "technique", 
      "contribution", 
      "MethodMTX", 
      "acid reactive substances (TBARS) productions", 
      "reactive substances (TBARS) productions", 
      "FD-4 permeation clearance", 
      "ConclusionsNAC"
    ], 
    "name": "Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats", 
    "pagination": "1117-1123", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050833962"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-009-1119-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19756603"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-009-1119-1", 
      "https://app.dimensions.ai/details/publication/pub.1050833962"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_480.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00280-009-1119-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-009-1119-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-009-1119-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-009-1119-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-009-1119-1'


 

This table displays all metadata directly associated to this object as RDF triples.

265 TRIPLES      22 PREDICATES      117 URIs      106 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-009-1119-1 schema:about N16353375486b49fd8f9e9016a4be4d05
2 N1af08776d2034137b8bbe94c94701b5f
3 N1cf2a7fd09ba4884a4161126fbb39f24
4 N27ffa157eafc4a4582d1656a85ccd2a5
5 N2ac4e8a9d9684dd8b2c99832e2e77a79
6 N39ba621447c242cd9c7db46dff4b8fc1
7 N3b2e754cb4274ec3a6bc8392a895a8fe
8 N43db1ff65a0347e59a1576254cc51a8b
9 N5d842112af8b49fba70f5c6ec4cdd896
10 N61d72427a1df4cf9b38d6fe392e50699
11 N665b832fa73f4cbdb50e7fcf9589952d
12 N894a0e4bb77e4f3ba097e497fe508467
13 N94186d490a6849978853623006583131
14 Nbe6329e82fac4a9f8db92cd8b375d11b
15 Nca2e6d2cf003448a97128aed9b09354e
16 Ned4d0f86d0714f7a8dd607c0ae49521e
17 Nf23f13d4dfc14801868720762d4d205d
18 Nf5fead83b9ba455cbaa8de3ed7003e4e
19 Nf766a8afc7684393a4fbbd6dfc5e44d2
20 Nf910fcc40d7041488c272f6e192899f6
21 Nfb4595583904428ca320896e97e6c707
22 Nfc36435b3f3a4e6cabf9eb74f1bddeac
23 anzsrc-for:11
24 anzsrc-for:1115
25 schema:author N34b0d4cd54ca4f97854df080d1e0f517
26 schema:citation sg:pub.10.1007/s00280-002-0460-4
27 sg:pub.10.1007/s00280-008-0809-4
28 sg:pub.10.1007/s002800050714
29 schema:datePublished 2009-09-16
30 schema:datePublishedReg 2009-09-16
31 schema:description PurposeWe previously demonstrated the increase of reactive oxygen species (ROS) production and myeloperoxidase (MPO) activity in the small intestine of methotrexate (MTX)-treated rats. In the present study, we investigated the role of ROS modulating intestinal mucosal permeability in this damage.MethodMTX (20 mg/kg body weight) was administered to rats intravenously. N-Acetylcysteine (NAC; 80 mg/kg body wt), an antioxidant and a precursor of glutathione (GSH) was administered to rats intraperitoneally to investigate the contribution of ROS to the intestinal permeability enhancement. Intestinal permeability was evaluated by determining that of a poorly absorbable marker, fluorescein isothiocyanate-labeled dextran (FD-4; average molecular mass, 4.4 kDa) using the in vitro everted intestine technique. The occurrence of oxidative stress in the small intestine was assayed by measuring chemiluminescence and thiobarbituric acid reactive substances (TBARS) productions in mucosal homogenates of the small intestine.ResultsThe mucosal permeability of FD-4 significantly (p < 0.01) increased in MTX-treated rats compared with control rats, as demonstrated by a twofold increase of FD-4 permeation clearance. This suggests an increase in paracellular permeability. Interestingly, the ROS production was observed preceding the increase of paracellular permeability. Treatment with NAC prevented the MTX-induced ROS production and the increase of paracellular permeability.ConclusionsNAC protected the small intestine of rats from MTX-induced change in paracellular permeability, suggesting that ROS played an important role in the enhanced paracellular permeability.
32 schema:genre article
33 schema:inLanguage en
34 schema:isAccessibleForFree false
35 schema:isPartOf N0c0b7fa800f14cc882fcea0a653505f6
36 N3f30328168294cc5a85438a5d05a39c5
37 sg:journal.1088364
38 schema:keywords ConclusionsNAC
39 FD-4
40 FD-4 permeation clearance
41 Intestinal permeability enhancement
42 MTX
43 MethodMTX
44 NAC
45 PurposeWe
46 ROS
47 ROS production
48 absorbable marker
49 acetylcysteine
50 acid reactive substances (TBARS) productions
51 activity
52 antioxidants
53 changes
54 chemiluminescence
55 clearance
56 contribution
57 contribution of ROS
58 control rats
59 damage
60 dextran
61 enhanced paracellular permeability
62 enhancement
63 fluorescein isothiocyanate
64 glutathione
65 homogenates
66 important role
67 increase
68 intestinal mucosal permeability
69 intestinal permeability
70 intestine
71 intestine technique
72 isothiocyanate
73 markers
74 methotrexate
75 methotrexate-treated rats
76 mucosal homogenates
77 mucosal permeability
78 myeloperoxidase activity
79 occurrence
80 oxidative stress
81 oxygen species (ROS) production
82 paracellular permeability
83 permeability
84 permeability enhancement
85 permeation clearance
86 precursor of glutathione
87 precursors
88 present study
89 production
90 rats
91 reactive oxygen species (ROS) production
92 reactive substances (TBARS) productions
93 role
94 role of ROS
95 small intestine
96 species production
97 stress
98 study
99 substance production
100 technique
101 thiobarbituric acid reactive substances (TBARS) production
102 treatment
103 twofold increase
104 schema:name Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats
105 schema:pagination 1117-1123
106 schema:productId N2e8f87285a1f424994330c0235127119
107 N617d8841cf2d45e783f7ba81d6a86c6d
108 N6f04dd3c3dfb45d29756e6569c704e6c
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050833962
110 https://doi.org/10.1007/s00280-009-1119-1
111 schema:sdDatePublished 2022-01-01T18:20
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher Ndd91df83f8784ed59e5f286f953c7a78
114 schema:url https://doi.org/10.1007/s00280-009-1119-1
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N0c0b7fa800f14cc882fcea0a653505f6 schema:issueNumber 6
119 rdf:type schema:PublicationIssue
120 N12d0b52f809e45f697bb4921e15267d1 rdf:first sg:person.01346736417.19
121 rdf:rest N24655cdc5a5a4d7f96fc5482d075195b
122 N16353375486b49fd8f9e9016a4be4d05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Permeability
124 rdf:type schema:DefinedTerm
125 N1af08776d2034137b8bbe94c94701b5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Intestinal Absorption
127 rdf:type schema:DefinedTerm
128 N1cf2a7fd09ba4884a4161126fbb39f24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Reactive Oxygen Species
130 rdf:type schema:DefinedTerm
131 N21fe5d8f6af342c3a377350a477a3101 schema:affiliation grid-institutes:grid.136304.3
132 schema:familyName Maeda
133 schema:givenName Tomoko
134 rdf:type schema:Person
135 N24655cdc5a5a4d7f96fc5482d075195b rdf:first sg:person.014523410741.77
136 rdf:rest N64e16409ece74f5eab4aee339ba305b5
137 N27ffa157eafc4a4582d1656a85ccd2a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Rats
139 rdf:type schema:DefinedTerm
140 N2ac4e8a9d9684dd8b2c99832e2e77a79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Dextrans
142 rdf:type schema:DefinedTerm
143 N2e8f87285a1f424994330c0235127119 schema:name pubmed_id
144 schema:value 19756603
145 rdf:type schema:PropertyValue
146 N34b0d4cd54ca4f97854df080d1e0f517 rdf:first N21fe5d8f6af342c3a377350a477a3101
147 rdf:rest N6353f9c5db3b4f04b0ad1bcf49ab1eb8
148 N39ba621447c242cd9c7db46dff4b8fc1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Antimetabolites, Antineoplastic
150 rdf:type schema:DefinedTerm
151 N3b2e754cb4274ec3a6bc8392a895a8fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Oxidative Stress
153 rdf:type schema:DefinedTerm
154 N3f30328168294cc5a85438a5d05a39c5 schema:volumeNumber 65
155 rdf:type schema:PublicationVolume
156 N43db1ff65a0347e59a1576254cc51a8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Glutathione
158 rdf:type schema:DefinedTerm
159 N5d842112af8b49fba70f5c6ec4cdd896 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Male
161 rdf:type schema:DefinedTerm
162 N617d8841cf2d45e783f7ba81d6a86c6d schema:name dimensions_id
163 schema:value pub.1050833962
164 rdf:type schema:PropertyValue
165 N61d72427a1df4cf9b38d6fe392e50699 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Acetylcysteine
167 rdf:type schema:DefinedTerm
168 N6353f9c5db3b4f04b0ad1bcf49ab1eb8 rdf:first sg:person.0752102243.39
169 rdf:rest Nccf0f062d5414a8a814553ae76b65828
170 N64e16409ece74f5eab4aee339ba305b5 rdf:first sg:person.015025434461.42
171 rdf:rest rdf:nil
172 N665b832fa73f4cbdb50e7fcf9589952d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Body Weight
174 rdf:type schema:DefinedTerm
175 N6f04dd3c3dfb45d29756e6569c704e6c schema:name doi
176 schema:value 10.1007/s00280-009-1119-1
177 rdf:type schema:PropertyValue
178 N894a0e4bb77e4f3ba097e497fe508467 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Injections, Intraperitoneal
180 rdf:type schema:DefinedTerm
181 N94186d490a6849978853623006583131 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Fluorescein-5-isothiocyanate
183 rdf:type schema:DefinedTerm
184 Nbe6329e82fac4a9f8db92cd8b375d11b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Methotrexate
186 rdf:type schema:DefinedTerm
187 Nca2e6d2cf003448a97128aed9b09354e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Thiobarbituric Acid Reactive Substances
189 rdf:type schema:DefinedTerm
190 Nccf0f062d5414a8a814553ae76b65828 rdf:first sg:person.013142761762.78
191 rdf:rest N12d0b52f809e45f697bb4921e15267d1
192 Ndd91df83f8784ed59e5f286f953c7a78 schema:name Springer Nature - SN SciGraph project
193 rdf:type schema:Organization
194 Ned4d0f86d0714f7a8dd607c0ae49521e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Injections, Intravenous
196 rdf:type schema:DefinedTerm
197 Nf23f13d4dfc14801868720762d4d205d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Animals
199 rdf:type schema:DefinedTerm
200 Nf5fead83b9ba455cbaa8de3ed7003e4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Rats, Wistar
202 rdf:type schema:DefinedTerm
203 Nf766a8afc7684393a4fbbd6dfc5e44d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Intestine, Small
205 rdf:type schema:DefinedTerm
206 Nf910fcc40d7041488c272f6e192899f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
207 schema:name Intestinal Mucosa
208 rdf:type schema:DefinedTerm
209 Nfb4595583904428ca320896e97e6c707 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name Time Factors
211 rdf:type schema:DefinedTerm
212 Nfc36435b3f3a4e6cabf9eb74f1bddeac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
213 schema:name Free Radical Scavengers
214 rdf:type schema:DefinedTerm
215 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
216 schema:name Medical and Health Sciences
217 rdf:type schema:DefinedTerm
218 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
219 schema:name Pharmacology and Pharmaceutical Sciences
220 rdf:type schema:DefinedTerm
221 sg:journal.1088364 schema:issn 0344-5704
222 1432-0843
223 schema:name Cancer Chemotherapy and Pharmacology
224 schema:publisher Springer Nature
225 rdf:type schema:Periodical
226 sg:person.013142761762.78 schema:affiliation grid-institutes:grid.412708.8
227 schema:familyName Ito
228 schema:givenName Kousei
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013142761762.78
230 rdf:type schema:Person
231 sg:person.01346736417.19 schema:affiliation grid-institutes:grid.136304.3
232 schema:familyName Hamada
233 schema:givenName Kazuma
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346736417.19
235 rdf:type schema:Person
236 sg:person.014523410741.77 schema:affiliation grid-institutes:grid.136304.3
237 schema:familyName Sekine
238 schema:givenName Shuichi
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014523410741.77
240 rdf:type schema:Person
241 sg:person.015025434461.42 schema:affiliation grid-institutes:grid.136304.3
242 schema:familyName Horie
243 schema:givenName Toshiharu
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015025434461.42
245 rdf:type schema:Person
246 sg:person.0752102243.39 schema:affiliation grid-institutes:grid.136304.3
247 schema:familyName Miyazono
248 schema:givenName Yuko
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752102243.39
250 rdf:type schema:Person
251 sg:pub.10.1007/s00280-002-0460-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008558863
252 https://doi.org/10.1007/s00280-002-0460-4
253 rdf:type schema:CreativeWork
254 sg:pub.10.1007/s00280-008-0809-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032804435
255 https://doi.org/10.1007/s00280-008-0809-4
256 rdf:type schema:CreativeWork
257 sg:pub.10.1007/s002800050714 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015512224
258 https://doi.org/10.1007/s002800050714
259 rdf:type schema:CreativeWork
260 grid-institutes:grid.136304.3 schema:alternateName Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8675, Chiba, Japan
261 schema:name Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8675, Chiba, Japan
262 rdf:type schema:Organization
263 grid-institutes:grid.412708.8 schema:alternateName Department of Pharmacy, Faculty of Medicine, The University of Tokyo Hospital, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan
264 schema:name Department of Pharmacy, Faculty of Medicine, The University of Tokyo Hospital, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan
265 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...